News

How is drug testing cost driven by Cost-Per-Positive?

by
Why Does Cost-Per-Positive Matter Most? Because it is an Objective-Based Measurement of the drug testing investment. Know your objectives to calculate your costs. Today, your drug testing costs may not return the results you look for. In other words, the services you pay for are lagging behind drug trends. A common question is "how much ... Read more

A Growing Epidemic Inside The Pandemic

by
CDC and DEA Cite a Growing Drug Overdose Epidemic Inside the COVID Pandemic   Record drug deaths create new and urgent challenges. Drug deaths in 2020 concern anyone who, like me, is a bit of a data geek. The most recently released CDC and DEA data paints a picture of a persistent epidemic. Beyond that, ... Read more

CDC Estimates 93,000 drug overdose deaths in 2020

by
CDC Estimates 93,000 drug overdose deaths in 2020 "Drug overdose deaths 2020" may sound glib. However, CDC data makes it official that 2020 eclipsed all previous records. As the Commonwealth Fund reports, with 93,331 dead the year was bad by any measure. Not surprisingly this comes on the heels of records in the two years ... Read more

Fentanyl Epidemic? 2021 could be the start.

by
Fentanyl epidemic?  Probably. 2020 overdose deaths give a clue. Is a fentanyl epidemic taking shape? An article from this week's New York Times paints an excellent picture of how quickly the drug ravages a community. Fentanyl deaths and overdoses are on the rise. The message is clear that fentanyl is the dominant drug threat for ... Read more

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

by
ACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel. In this important role, Sarah will be responsible for directing and managing all of the company’s legal activities. She will report directly to the company’s CEO. Sarah rejoins Psychemedics from ... Read more

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

by
ACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek had joined the Company as Vice President, Controller. In this important role, Andrew will be responsible for directing and managing all of the Company’s financial activities, including external reporting and internal analysis. He will report directly to the Company’s ... Read more

Robyn C. Davis Joins Psychemedics Board of Directors

by
ACTON, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics Corporation effective immediately. Ms. Davis will be filling the vacancy created by the untimely passing this past December of Clint Allen, a long-time and dedicated Psychemedics ... Read more

Are “New” Substance Abusers Slipping By Your Drug Test?

by
Are "New" Substance Abusers Slipping By Your Drug Test? This new year's challenges; some familiar and some not. “Your post-COVID workplace may be more vulnerable than ever. Be prepared .” The turn of a new year is when we resolve to reassess and adjust everything from our diets to our finances to our time spent ... Read more

Safety Has No Secrets: Psychemedics Overview

by
Prologue to "In Safety There Are No Secrets":  How hair testing works. In this 10-minute video, Psychemedics Executive Vice President Charlie Doucot explains the Science behind hair testing used by our three "Safety Has No Secrets" panelists. In this video, you'll learn how it works, why it is the most simple and sanitary drug test ... Read more